Chief Financial Officer
Mon, Apr 20, 2026
Apr 20
exercised or converted securities in PCRX
7,714 shares @ $0.00
Decreased holdings by -4.40%
Net across this filing: 0.00% (+0 shares)
Option Exercise
Sale tied to a same-time option exercise
PCRXPacira BioSciences, Inc.
HealthcareDrug Manufacturers - Specialty & Generic
1D0.00%
1W+4.02%
1M-7.73%
3M—
6M—
1Y—